Ratiopharm Ulm
| Player | PTS | REB | AST | MIN | 2M-2A | 3M-3A | FG% | 1M-1A | FT% | OR | DR | STL | BLK | TO | EFF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 | 4 | 3 | 27 | 7-10 | 2-4 | 64.3% | 2-2 | 100.0% | 1 | 3 | 1 | 0 | 0 | 25 | |
| 14 | 4 | 2 | 24 | 5-8 | 1-3 | 54.5% | 1-2 | 50.0% | 0 | 4 | 1 | 3 | 3 | 15 | |
| 13 | 3 | 2 | 21 | 4-5 | 1-2 | 71.4% | 2-2 | 100.0% | 0 | 3 | 1 | 1 | 4 | 14 | |
| 10 | 3 | 3 | 9 | 2-4 | 2-3 | 57.1% | 0-0 | - | 1 | 2 | 1 | 0 | 1 | 13 | |
| 8 | 4 | 2 | 13 | 2-3 | 0-2 | 40.0% | 4-4 | 100.0% | 3 | 1 | 2 | 1 | 1 | 13 | |
| 7 | 1 | 1 | 17 | 2-2 | 1-1 | 100.0% | 0-0 | - | 0 | 1 | 2 | 1 | 1 | 11 | |
| 5 | 4 | 1 | 24 | 1-3 | 1-3 | 33.3% | 0-0 | - | 0 | 4 | 1 | 1 | 1 | 7 | |
| 3 | 0 | 0 | 18 | 0-2 | 1-5 | 14.3% | 0-0 | - | 0 | 0 | 1 | 0 | 2 | 4 | |
|
|
82 | 23 | 14 | 23-37 | 9-23 | 53.3% | 9-10 | 90% | 5 | 18 | 10 | 7 | 13 | 102 |
Hamburg Towers
| Player | PTS | REB | AST | MIN | 2M-2A | 3M-3A | FG% | 1M-1A | FT% | OR | DR | STL | BLK | TO | EFF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 | 3 | 0 | 28 | 3-3 | 3-4 | 85.7% | 2-3 | 66.7% | 1 | 2 | 1 | 0 | 1 | 18 | |
| 16 | 6 | 3 | 20 | 8-11 | 0-0 | 72.7% | 0-0 | - | 1 | 5 | 0 | 1 | 3 | 20 | |
| 16 | 4 | 1 | 21 | 5-9 | 2-5 | 50.0% | 0-2 | 0.0% | 2 | 2 | 0 | 0 | 0 | 12 | |
| 13 | 3 | 9 | 22 | 1-3 | 3-6 | 44.4% | 2-2 | 100.0% | 1 | 2 | 0 | 0 | 2 | 18 | |
| 6 | 3 | 2 | 18 | 1-1 | 1-5 | 33.3% | 1-1 | 100.0% | 2 | 1 | 1 | 0 | 1 | 7 | |
| 2 | 1 | 1 | 22 | 0-2 | 0-2 | 0.0% | 2-2 | 100.0% | 1 | 0 | 1 | 0 | 1 | 0 | |
| 2 | 2 | 1 | 15 | 1-2 | 0-1 | 33.3% | 0-0 | - | 0 | 2 | 1 | 0 | 5 | 1 | |
| 0 | 4 | 2 | 8 | 0-1 | 0-2 | 0.0% | 0-0 | - | 1 | 3 | 0 | 1 | 3 | 1 | |
| 0 | 0 | 0 | 3 | 0-2 | 0-0 | 0.0% | 0-0 | - | 0 | 0 | 0 | 0 | 0 | 2 | |
|
|
72 | 26 | 19 | 19-34 | 9-25 | 47.5% | 7-10 | 70% | 9 | 17 | 4 | 2 | 16 | 79 |